InfiCure Bio has been accepted to Business Swedens Catalyst program, which is a program aimed at helping companies scale globally. The focus for InfiCure Bio is the Korean market and Business Sweden will help InfiCure to [...]

The CEO of InfiCure Bio presented the company at LSX Nordics in Stockholm on August 28th. To watch the presentation click here.  

InfiCure Bio will be presenting at the LSX Nordic Congress in Stockholm on August 28th. The company will be presenting during the start up showcase as one of the growth stage private companies.

InfiCure Bio has received additional funding from NLC InfiCure Bio and Partnerinvest Övre Norrland to speed up the validation of additional indications in the NIF mouse. This is a golden opportunity to broaden our customer [...]

InfiCure Bio is pleased to announce that Lena Söderström has been appointed new Chairman of the Board. Lena has longstanding experience from numerous positions in the life science sector and her knowledge, together with her [...]

InfiCure Bio will be present at this years EASL in Vienna. Julia will present the NIF mouse and Dan will talk about imaging in livers of NIF mice. If you're at EASL, do not hesitate [...]